Cantor Fitzgerald Reaffirms Hold Rating for Envision Healthcare (EVHC)

Envision Healthcare (NYSE:EVHC)‘s stock had its “hold” rating reissued by analysts at Cantor Fitzgerald in a research report issued to clients and investors on Friday, January 5th. They presently have a $37.00 price objective on the stock. Cantor Fitzgerald’s price target would indicate a potential upside of 1.34% from the company’s previous close.

The analysts wrote, “Increasing 2018 estimates and updating PT. We are increasing our 2018 adjusted EPS estimate to $3.95 from $3.40 to reflect a lower corporate tax rate that adds $0.57 to adjusted EPS, offset by changes in the timing and estimated net proceeds from the AMR divestiture, which is now expected to close in 1Q18. Our adjusted 2018 EBITDA estimate remains $982 million, but our new price target reflects higher free cash flow from the lower taxes, and incremental margin improvements from reduced overhead labor costs.””

Several other research analysts have also issued reports on the company. Bank of America decreased their target price on Envision Healthcare from $72.00 to $60.00 and set a “buy” rating for the company in a research report on Monday, October 9th. Oppenheimer decreased their target price on Envision Healthcare from $77.00 to $40.00 and set an “outperform” rating for the company in a research report on Thursday, November 2nd. KeyCorp decreased their target price on Envision Healthcare from $67.00 to $37.00 and set an “overweight” rating for the company in a research report on Thursday, November 2nd. Canaccord Genuity reissued a “buy” rating and issued a $32.00 target price (down previously from $68.00) on shares of Envision Healthcare in a research report on Thursday, November 2nd. Finally, Citigroup lowered Envision Healthcare from a “buy” rating to a “neutral” rating and set a $31.00 target price for the company. in a research report on Thursday, November 2nd. One research analyst has rated the stock with a sell rating, eight have given a hold rating and nine have issued a buy rating to the stock. Envision Healthcare has a consensus rating of “Hold” and a consensus target price of $41.00.

Envision Healthcare (NYSE EVHC) traded up $0.38 during midday trading on Friday, reaching $36.51. The company’s stock had a trading volume of 1,646,512 shares, compared to its average volume of 2,630,000. Envision Healthcare has a 1-year low of $23.77 and a 1-year high of $73.00. The company has a current ratio of 3.01, a quick ratio of 3.00 and a debt-to-equity ratio of 0.89. The stock has a market cap of $4,420.00, a PE ratio of -24.50, a P/E/G ratio of 0.94 and a beta of 0.57.

Envision Healthcare (NYSE:EVHC) last released its quarterly earnings data on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.81 by ($0.08). Envision Healthcare had a positive return on equity of 4.88% and a negative net margin of 6.39%. The business had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $2.03 billion. During the same quarter last year, the business posted $1.13 EPS. The company’s quarterly revenue was up 142.0% compared to the same quarter last year. equities analysts forecast that Envision Healthcare will post 2.5 EPS for the current year.

Hedge funds have recently bought and sold shares of the stock. Commonwealth Bank of Australia increased its position in Envision Healthcare by 24.3% during the 2nd quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock valued at $130,000 after buying an additional 410 shares in the last quarter. Flinton Capital Management LLC increased its position in Envision Healthcare by 18.7% during the 2nd quarter. Flinton Capital Management LLC now owns 4,464 shares of the company’s stock valued at $280,000 after buying an additional 704 shares in the last quarter. D.A. Davidson & CO. increased its position in Envision Healthcare by 30.0% during the 2nd quarter. D.A. Davidson & CO. now owns 4,589 shares of the company’s stock valued at $287,000 after buying an additional 1,059 shares in the last quarter. PNC Financial Services Group Inc. increased its position in Envision Healthcare by 1.5% during the 2nd quarter. PNC Financial Services Group Inc. now owns 4,848 shares of the company’s stock valued at $304,000 after buying an additional 70 shares in the last quarter. Finally, Profund Advisors LLC increased its position in Envision Healthcare by 5.0% during the 2nd quarter. Profund Advisors LLC now owns 5,102 shares of the company’s stock valued at $320,000 after buying an additional 241 shares in the last quarter.

WARNING: “Cantor Fitzgerald Reaffirms Hold Rating for Envision Healthcare (EVHC)” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another site, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.dispatchtribunal.com/2018/01/28/envision-healthcare-evhc-receives-hold-rating-from-cantor-fitzgerald.html.

About Envision Healthcare

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Analyst Recommendations for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply